Pharmacists will be able to:

Pharmacy technicians will be able to:

1.      Describe key updates in the 2026 GOLD Report related to disease activity and the revised criteria defining GOLD A, B, and E categories

2.      Differentiate initial versus follow-up pharmacologic treatment strategies for COPD using updated GOLD treatment algorithms and figures

3.      Evaluate the role of biologic therapy in COPD based on new evidence summarized in the 2026 GOLD report

4.      Apply updated vaccination recommendations and comorbidity considerations to optimize comprehensive COPD management in clinical practice

5.      Identify medication classes and therapies newly emphasized in the 2026 GOLD Report

6.      List differences between initial and follow-up COPD treatment pathways

7.      Distinguish maintenance therapies from treatments used to reduced COPD exacerbations

8.      Identify updates to vaccination recommendations for patients with COPD that may impact medication histories and immunization documentation